Meyer Colin John 4
4 · REATA PHARMACEUTICALS INC · Filed May 17, 2023
Insider Transaction Report
Form 4
Meyer Colin John
See Remarks
Transactions
- Sale
Class A common stock
2023-05-15$85.77/sh−1,139$97,695→ 78,998 total - Sale
Class A common stock
2023-05-15$84.76/sh−4,469$378,778→ 80,137 total - Sale
Class A common stock
2023-05-16$80.94/sh−625$50,590→ 78,373 total
Footnotes (3)
- [F1]The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $84.3884 to $85.085 The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $85.731 to $85.86. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.